Columbus Macro, LLC Bristol Myers Squibb CO Transaction History

Columbus Macro, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$65.71 - $74.53 $2,825 - $3,204	-43 Reduced 0.9%	4,741 $328,000
Q4 2022 Feb 02, 2023	SELL	$68.48 - $81.09 $9,587 - $11,352	-140 Reduced 2.84%	4,784 $344,000
Q3 2022 Oct 21, 2022	SELL	$0.13 - $76.84 $30 - $18,211	-237 Reduced 4.59%	4,924 $350,000
Q2 2022 Jul 27, 2022	BUY	$72.62 - $79.98 $2,541 - $2,799	35 Added 0.68%	5,161 $399,000
Q1 2022 Apr 26, 2022	SELL	$61.48 - $73.72 $6,209 - $7,445	-101 Reduced 1.93%	5,126 $376,000
Q4 2021 Jan 21, 2022	SELL	$53.63 - $62.52 $18,234 - $21,256	-340 Reduced 6.11%	5,227 $326,000
Q3 2021 Oct 22, 2021	SELL	$59.17 - $69.31 $2,899 - $3,396	-49 Reduced 0.87%	5,567 $331,000
Q2 2021 Jul 21, 2021	SELL	$61.91 - $67.42 $619 - $674	-10 Reduced 0.18%	5,616 $375,000
Q1 2021 Apr 23, 2021	SELL	$59.34 - $66.74 $50,082 - $56,328	-844 Reduced 13.04%	5,626 $357,000
Q4 2020 Jan 26, 2021	SELL	$57.74 - $65.43 $71,193 - $80,675	-1,233 Reduced 16.01%	6,470 $404,000
Q3 2020 Oct 30, 2020	SELL	$57.43 - $63.64 $64,895 - $71,913	-1,130 Reduced 12.79%	7,703 $464,000
Q2 2020 Jul 31, 2020	SELL	$54.82 - $64.09 $138,365 - $161,763	-2,524 Reduced 22.22%	8,833 $519,000
Q1 2020 May 04, 2020	SELL	$46.4 - $67.43 $328,140 - $476,864	-7,072 Reduced 38.37%	11,357 $633,000
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $906,891 - $1.18 Million	18,429 New	18,429 $1.18 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Columbus Macro, LLC, based on Form 13F filings with the SEC.

Stay updated on Columbus Macro, LLC with notifications on news.